Laurus Labs Q3 Results: Profit jumps 32% YoY on demand for drug ingredients
Laurus Labs said revenue from its Synthesis and active pharmaceutical ingredients (API) businesses, each of which account for more than 40% of total revenue, rose 210% and 49%, respectively, in the latest quarter.
